Physician profile
Beric Berlioz
NPI 1093240061
$16,500.81
in general payments reported to CMS, 2019-2025
35 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $1,036 · 2023: $2,821 · 2024: $1,358 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,208 · Travel and Lodging: $730 · Education: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,207.86 |
| Travel and Lodging | $729.52 |
| Education | $226.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,838.06 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $1,545.20 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Bionic Navigator |
| Collegium Pharmaceutical, INC. | $659.80 | 2022-2025 | Xtampza, Belbuca |
| Nevro Corp. | $431.32 | 2021-2024 | Senza |
| Painteq LLC | $415.04 | 2023-2024 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $368.12 | 2023-2025 | Relistor |
| Stryker Corporation | $308.47 | 2023-2025 | Mild Device Kit, Spinejack |
| Abbvie INC. | $302.79 | 2023-2025 | Botox, Qulipta, Ubrelvy |
| Abbott Laboratories | $248.25 | 2022-2023 | Proclaim, Eterna |
| Tersera Therapeutics LLC | $207.83 | 2022-2025 | Prialt |
| Mml US, INC. | $121.66 | 2022 | |
| Saluda Medical Americas, INC. | $117.55 | 2025 | Evoke |
| Ibsa Pharma INC. | $109.88 | 2023-2025 | Licart, Tirosint, Flector |
| Pfizer INC. | $80.07 | 2024 | |
| Almatica Pharma LLC | $79.68 | 2022-2023 | Gralise |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $75.57 | 2023-2025 | Zubsolv |
| Alnylam Pharmaceuticals INC. | $54.48 | 2023-2024 | Givlaari |
| Valinor Pharma, LLC | $52.06 | 2023-2024 | Movantik |
| Nalu Medical, INC. | $50.81 | 2023-2024 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $50.50 | 2024 | Prolate, Nalocet |
| Idorsia Pharmaceuticals US INC | $50.05 | 2023-2025 | Quviviq, Quviviq |
| Vertos Medical, INC. | $47.15 | 2023-2024 | Mild Device Kit |
| Avanos Medical | $35.39 | 2024 | Standard Rf Disposables |
| Biohaven Pharmaceutical Holding Company LTD. | $34.70 | 2022 | |
| Lilly USA, LLC | $25.56 | 2023 | Emgality, Reyvow |
| Lundbeck LLC | $25.37 | 2023 | Vyepti |
| Alevio, LLC | $21.85 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Tonix Medicines, INC. | $21.74 | 2025 | Tonmya |
| Globus Medical, INC. | $20.77 | 2025 | Senza |
| Depuy Synthes Sales INC. | $18.85 | 2023 | Monovisc |
| Amneal Pharmaceuticals LLC | $18.00 | 2023 | Lyvispah |
| Si-Bone, INC. | $17.66 | 2025 | |
| Scilex Pharmaceuticals INC. | $16.68 | 2024 | |
| Trevena, INC. | $15.59 | 2022 | |
| Indivior INC. | $14.31 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beric Berlioz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.